Professor Ciechanover is currently a Distinguished Research Professor at the Cancer and Vascular Biology Research Center of the Rappaport Research Institute and Faculty of Medicine at the Technion-Israel Institute of Technology. As a graduate student at the Technion with Dr. Avram Hershko and in collaboration with Dr. Irwin A. Rose from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, Professor Ciechanover discovered the ubiquitin-mediated proteolytic system. The three were awarded the 2004 Nobel Prize in Chemistry for their discovery. In addition, Professor Ciechanover received the 2000 Albert Lasker Award for Basic Medical Research and the 2003 Israel Prize in Biology. He is a member (Foreign) of the National Academy of Science of the United States, the Pontifical Academy of Science (Vatican), and the Israeli Academy of Science and Humanities. Professor Ciechanover received an MS and a MD from the Hadassah Medical School of the Hebrew University of Jerusalem and a Doctorate of Science from the Technion-Israel Institute of technology. He trained as a post-doctoral fellow at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts.

 Cancer Biology